BLSM BlossomHill Therapeutics, Inc.
Nasdaq · SEC CIK 1839970 · EDGAR
- Bought, last 12 months
- $25.18M 6 purchases by 6 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 11 since 2026-08-10, latest 2026-08-12 16:46
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| GORDON CARL L | Dir | $10.00M | — |
| ORBIMED ADVISORS LLC | Dir | $10.00M | — |
| Chen Bihua | Dir, 10% | $5.00M | — |
| Schmid John P. | Dir | $96.0K | — |
| Liptak Vincent Paul | GC | $74.7K | — |
| Keyes Jason A | CFO | $11.2K | — |
| Agrawal Sundeep | Dir | — | — |
| Cui Jingrong Jean | Pres, CEO, Dir, 10% | — | — |
| Li Yishan | Executive COB, Dir, 10% | — | — |
Transactions 13
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-12 16:46 | 2026-08-10 | BLSM | GORDON CARL L | Dir | C - Cnv Deriv | — | +2.09M | 2.09M | New | — |
| DI | 2026-08-12 16:46 | 2026-08-10 | BLSM | GORDON CARL L | Dir | P - Purchase | $16.00 | +625.0K | 2.71M | +30% | +$10.00M |
| DMI | 2026-08-12 16:43 | 2026-08-10 | BLSM | ORBIMED ADVISORS LLC | Dir | C - Cnv Deriv | — | +2.09M | 2.09M | New | — |
| DI | 2026-08-12 16:43 | 2026-08-10 | BLSM | ORBIMED ADVISORS LLC | Dir | P - Purchase | $16.00 | +625.0K | 2.71M | +30% | +$10.00M |
| 2026-08-10 18:35 | 2026-08-10 | BLSM | Schmid John P. | Dir | P - Purchase | $16.00 | +6,000 | 6,000 | New | +$96.0K | |
| DMI | 2026-08-10 18:32 | 2026-08-10 | BLSM | Chen Bihua | Dir, 10% | C - Cnv Deriv | — | +3.30M | 3.30M | New | — |
| DI | 2026-08-10 18:32 | 2026-08-10 | BLSM | Chen Bihua | Dir, 10% | P - Purchase | $16.00 | +312.5K | 3.61M | +9% | +$5.00M |
| DI | 2026-08-10 18:29 | 2026-08-10 | BLSM | Agrawal Sundeep | Dir | C - Cnv Deriv | — | +578.5K | 578.5K | New | — |
| D | 2026-08-10 18:27 | 2026-08-10 | BLSM | Keyes Jason A | CFO | P - Purchase | $16.00 | +700 | 700 | New | +$11.2K |
| DM | 2026-08-10 18:26 | 2026-08-07+ | BLSM | Liptak Vincent Paul | GC | P - Purchase | $15.89 | +4,700 | 111.4K | +4% | +$74.7K |
| DI | 2026-08-10 18:26 | 2026-08-10 | BLSM | Liptak Vincent Paul | GC | C - Cnv Deriv | — | +22.7K | 22.7K | New | — |
| DMI | 2026-08-10 18:23 | 2026-08-10 | BLSM | Li Yishan | Executive COB, Dir, 10% | C - Cnv Deriv | — | +1.84M | 124.8K | New | — |
| DMI | 2026-08-10 18:22 | 2026-08-10 | BLSM | Cui Jingrong Jean | Pres, CEO, Dir, 10% | C - Cnv Deriv | — | +1.84M | 124.8K | New | — |